[Congressional Record Volume 169, Number 120 (Thursday, July 13, 2023)]
[Senate]
[Page S2605]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 447. Mr. BLUMENTHAL submitted an amendment intended to be proposed 
by him to the bill S. 2226, to authorize appropriations for fiscal year 
2024 for military activities of the Department of Defense, for military 
construction, and for defense activities of the Department of Energy, 
to prescribe military personnel strengths for such fiscal year, and for 
other purposes; which was ordered to lie on the table; as follows:

       At the appropriate place in title VII, insert the 
     following:

     SEC. __. REPORT ON COVERAGE OF MIGRAINE PREVENTION AND 
                   TREATMENT DEVICES.

       (a) Findings.--Congress finds the following:
       (1) Members of the Armed Forces are diagnosed with or 
     exhibit symptoms of migraines at a rate that is 3 times 
     higher than the general population.
       (2) 1 in 3 members of the Armed Forces experience severe 
     headaches and migraines within the first months after 
     returning from deployment.
       (3) Women are 3 to 6 times more likely than men to 
     experience migraines.
       (4) Operational barriers, performance-limiting adverse 
     effects, and the ineffectiveness of drug treatments for some 
     members of the Armed Forces demonstrate the necessity of 
     increasing the availability of non-pharmacological devices 
     that can treat and prevent migraines.
       (b) Report.--Not later than 120 days after the date of the 
     enactment of this Act, the Secretary of Defense shall submit 
     to Congress a report on the plan of the Secretary to provide 
     non-pharmacological, neuromodulation migraine prevention and 
     treatment devices that have been cleared by the Food and Drug 
     Administration to members of the Armed Forces who could 
     benefit from those devices.
                                 ______